Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd.
NSE: ALIVUS | BSE: 543322
Mid-range Performer
Download real time
1047.45
100.60
(
10.62
%)
3.2M
NSE+BSE Volume
High volume+gain today
NSE
19 Sep, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
BUY STOCK
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alivus Life Sciences Ltd. Corporate Filings & Announcements
Latest corporate announcements and filings from Alivus Life Sciences Ltd. on BSE
Get corporate announcements alerts
Hourly Digest
Daily Digest
All
News
Earnings Calls
Corporate Announcements
Research Reports
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
132 Votes:
Buy
75.0%
Sell
12.12%
Hold
12.88%
BUY
SELL
HOLD
RESEARCH REPORTS
Buy
SEE REPORTS >
18 Mar 2025, 12:00AM
pdf
Alivus Life Sciences..
by BP Wealth
| Target:
1317
| Upside:
25.73%
Buy
SEE REPORTS >
16 Jul 2024
pdf
Alivus Life Sciences..
by Hem Securities
| Target:
987
Target met
All reports of ALIVUS